S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33

Akoustis Technologies Stock Forecast, Price & News

0.00 (0.00 %)
(As of 09/24/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume359,072 shs
Average Volume636,623 shs
Market Capitalization$532.83 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive AKTS News and Ratings via Email

Sign-up to receive the latest news and ratings for Akoustis Technologies and its competitors with MarketBeat's FREE daily newsletter.

Akoustis Technologies logo

About Akoustis Technologies

Akoustis Technologies, Inc. is a filter solutions company, which engages in the development, design, and manufacture of radio frequency (RF) filter products. It operates through the Foundry Fabrication Services; and RF Filters segments. The Foundry Fabrication Services segment consists of engineering review services and STC-MEMS foundry services. The RF Filters segment includes amplifier and filter product sales, and grant revenue. The company was founded by Jeffrey B. Shealy in 2014 and is headquartered in Huntersville, NC.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

2.20 out of 5 stars

Computer And Technology Sector

272nd out of 858 stocks

Telephone & Telegraph Apparatus Industry

5th out of 19 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Akoustis Technologies (NASDAQ:AKTS) Frequently Asked Questions

Is Akoustis Technologies a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Akoustis Technologies stock.
View analyst ratings for Akoustis Technologies
or view top-rated stocks.

What stocks does MarketBeat like better than Akoustis Technologies?

Wall Street analysts have given Akoustis Technologies a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Akoustis Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Akoustis Technologies' next earnings date?

Akoustis Technologies is scheduled to release its next quarterly earnings announcement on Monday, November 1st 2021.
View our earnings forecast for Akoustis Technologies

How were Akoustis Technologies' earnings last quarter?

Akoustis Technologies, Inc. (NASDAQ:AKTS) released its earnings results on Sunday, August, 29th. The technology company reported ($0.19) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.18) by $0.01. The technology company had revenue of $2.20 million for the quarter, compared to analyst estimates of $2.50 million. Akoustis Technologies had a negative trailing twelve-month return on equity of 42.85% and a negative net margin of 667.21%. The firm's quarterly revenue was up 501.1% compared to the same quarter last year.
View Akoustis Technologies' earnings history

How has Akoustis Technologies' stock price been impacted by COVID-19?

Akoustis Technologies' stock was trading at $5.31 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AKTS shares have increased by 95.3% and is now trading at $10.37.
View which stocks have been most impacted by COVID-19

What price target have analysts set for AKTS?

5 brokers have issued 12 month target prices for Akoustis Technologies' stock. Their forecasts range from $14.00 to $20.00. On average, they expect Akoustis Technologies' stock price to reach $17.40 in the next twelve months. This suggests a possible upside of 67.8% from the stock's current price.
View analysts' price targets for Akoustis Technologies
or view top-rated stocks among Wall Street analysts.

Who are Akoustis Technologies' key executives?

Akoustis Technologies' management team includes the following people:

What other stocks do shareholders of Akoustis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include Inseego (INSG), NVIDIA (NVDA), Square (SQ), Editas Medicine (EDIT), Marvell Technology (MRVL), Alibaba Group (BABA), Invitae (NVTA), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP) and JD.com (JD).

What is Akoustis Technologies' stock symbol?

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

Who are Akoustis Technologies' major shareholders?

Akoustis Technologies' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (5.49%), Vanguard Group Inc. (4.48%), Ashford Capital Management Inc. (3.84%), Handelsbanken Fonder AB (2.28%), Silverback Asset Management LLC (1.83%) and Geode Capital Management LLC (1.46%). Company insiders that own Akoustis Technologies stock include Arthur Geiss, David Aichele, Jeffrey B Shealy, Jeffrey B Shealy, Jeffrey Mcmahon, Kenneth Boller, Rohan Houlden, Steven Denbaars and Suzanne B Rudy.
View institutional ownership trends for Akoustis Technologies

Which major investors are selling Akoustis Technologies stock?

AKTS stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Susquehanna International Group LLP, Goldman Sachs Group Inc., Advisor Group Holdings Inc., Cambridge Investment Research Advisors Inc., Bank of America Corp DE, Taylor Frigon Capital Management LLC, and Squarepoint Ops LLC. Company insiders that have sold Akoustis Technologies company stock in the last year include Arthur Geiss, David Aichele, Jeffrey B Shealy, Jeffrey Mcmahon, Kenneth Boller, Rohan Houlden, Steven Denbaars, and Suzanne B Rudy.
View insider buying and selling activity for Akoustis Technologies
or view top insider-selling stocks.

Which major investors are buying Akoustis Technologies stock?

AKTS stock was purchased by a variety of institutional investors in the last quarter, including Penserra Capital Management LLC, Connors Investor Services Inc., M&G Investment Management Ltd., Endurance Wealth Management Inc., Silverback Asset Management LLC, Vanguard Group Inc., BlackRock Inc., and State Street Corp.
View insider buying and selling activity for Akoustis Technologies
or or view top insider-buying stocks.

How do I buy shares of Akoustis Technologies?

Shares of AKTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Akoustis Technologies' stock price today?

One share of AKTS stock can currently be purchased for approximately $10.37.

How much money does Akoustis Technologies make?

Akoustis Technologies has a market capitalization of $532.83 million and generates $6.62 million in revenue each year. The technology company earns $-44,160,000.00 in net income (profit) each year or ($0.78) on an earnings per share basis.

How many employees does Akoustis Technologies have?

Akoustis Technologies employs 99 workers across the globe.

What is Akoustis Technologies' official website?

The official website for Akoustis Technologies is www.akoustis.com.

Where are Akoustis Technologies' headquarters?

Akoustis Technologies is headquartered at 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078.

How can I contact Akoustis Technologies?

Akoustis Technologies' mailing address is 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078. The technology company can be reached via phone at (704) 997-5735 or via email at [email protected].

This page was last updated on 9/25/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.